期刊文献+

β-胡萝卜素抑制MCF-7细胞生长上调过氧化酶体增殖物激活受体γ(PPARγ)表达 被引量:1

β-Carotene Inhibits Cell Viability and Up-regulates Peroxisome Proliferator-activated Receptor γ(PPARγ) Expression in MCF-7 Breast Cancer Cells
下载PDF
导出
摘要 为了研究过氧化酶体增殖物激活受体γ(PPARγ)表达在β-胡萝卜素影响乳腺癌MCF-7细胞活力中所起的作用,采用MTT法测定细胞活力、Western印迹检测细胞中PPARγ的蛋白质水平,用RT-PCR从mRNA水平检测细胞内PPARγ、P21WAF1/CIP1、COX-2和P27表达.研究发现,β-胡萝卜素显著抑制人乳腺癌细胞株MCF-7细胞的生长,β-胡萝卜素对细胞生长的抑制作用呈现出时间和计量依赖关系;β-胡萝卜素能够呈现时间效应地从mRNA和蛋白质水平显著上调PPARγ的表达,β-胡萝卜素能够通过PPARγ调节P21WAF1/CIP1和COX-2 mRNA水平;PPARγ的抑制剂GW9662和抗氧化剂还原型谷胱甘肽(GSH)都能部分阻止由β-胡萝卜素引起的细胞活力下降.研究结果提示,激活PPARγ途径和调制细胞氧化状态是β-胡萝卜素对乳腺癌细胞MCF-7的生长抑制效应原因之一. Whether the function of carotenoids on breast cell growth is mediated by peroxisome proliferatoractivated receptor γ (PPARγ) signaling pathway remained largely unknown. We tested the PPAR γ expression for the inhibition of MCF-7 human breast cancer cells under the treatments of β-carotene. The cell viability was determined by MTT assay, PPARγ protein expression was analyzed by Westem blotting and the mRNA levels of PPARγ, P21^WAF1/CIP1, COX-2, and P27 were evaluated by RT-PCR. The results showed that β-carotene inhibited the proliferation of MCF-7 cells in a dose- and time-dependent manner. β-Carotene exposure significantly up-regnlated the PPARγ mRNA level and protein expression in time-dependently. β-Carotene was also able to modulate P21^WAF1/CIP1 and COX-2 mRNA levels dependent to PPART. Pre-ineubation with PPARγ antagonist GW9662 and reduced glutathione (GSH) partly rescued the loss of cells. It suggested that the enhancement of PPARγ expression and the modulation of intercellular redox status may be a cause of MCF-7 cell growth inhibition by β-carotene.
出处 《中国生物化学与分子生物学报》 CAS CSCD 北大核心 2009年第6期542-548,共7页 Chinese Journal of Biochemistry and Molecular Biology
基金 国家自然科学基金(No.30470423)~~
关键词 Β-胡萝卜素 MCF-7人乳腺癌细胞 过氧化酶体增殖物激活受体γ(PPARγ) β-carotene human breast cancer MCF-7 cells peroxisome proliferator-activated receptor γ (PPARγ)
  • 相关文献

参考文献33

  • 1Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk[J]. Am J Clin Nutr, 2003, 78 (3Suppl) :559s-569s.
  • 2Tamimi R M, Hankinson S E, Campos H, et al. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer[J]. Am J Epidemiol, 2005,161(2) : 153-160.
  • 3Toniolo P, Van Kappel A L, Akhmedkhanov A, et al. Serum Carotenoids and Breast Cancer [ J]. Am J Epidemiol, 2001, 153 (12) : 1142-1147.
  • 4Shultz T D, Chew B P, Seaman W R, et al. Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells[J]. Cancer Lett, 1992, 63 (2) : 125-133.
  • 5Prakash P, Russell R M, Krinsky N I. In vitro inhibition of proliferation of estrogen-dependent and estrogen-independent human breast cancer cells treated with carotenoids or retinoids [ J ]. J Nutr, 2001, 131(5) : 1574-1580.
  • 6李忠,王颖明,莫宝庆.类胡萝卜素对人乳腺癌细胞增殖及bcl-2基因表达的影响[J].中华预防医学杂志,2002,36(4):254-257. 被引量:5
  • 7Theocharis S, Kanelli H, Politl E, et al. Expression of peroxisome proliferator activated receptor-gamma in non-small cel1 lung carcinoma: correlation with histological type and grade [ ] ]. Lung Cancer, 2002, 36(3):249-255.
  • 8Pandhare J, Cooper S K, Phang J M. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-actived receptor gamma-dependent and -independent mechanisms[J]. ] Biol Chem, 2006, 281(4) :2044-2052.
  • 9Lu J, Imamura K, Nomura S, et al. Chemopreventive effect of peroxisome proliferator-activated receptor gamma on gastric carcinogenesis in mice[ J]. Cancer Res, 2005, 65 ( 11 ) :4769-4774.
  • 10Knight B, Yeap B B, Yeoh G C, et al. Inhibition of adult liver progenitor ( oval ) cell growth and wiability by an agonist of the peroxisome proliferator activated receptor (PPAR)family member {gamma } , but not { alpha} or { delta} [ J ]. Carcinogenesis, 2005, 26 (10) : 1782-1792.

二级参考文献1

共引文献4

同被引文献43

  • 1Tontonoz P, Spiegelman B M. Fat and beyond: the diverse biology of PPARγ[J].Annu Rev Bioehem, 2008, 77 ( 1 ) :289-312.
  • 2Lehrke M, Lazar MA. The many faces of PPARγ [ J ]. Cell, 2005, 123 (6) : 993-999.
  • 3Wan Y. PPARγ in bone homeostasis [J]. Trends Endocrinol Metab,2010, 21(12) : 722-728.
  • 4Klotz L, Burgdoff S, Dani I, et al. The nuclear receptor PPAγ selectively inhibits Th17 differentiation in a T cell-intrinsic fashion and suppresses CNS autoimmunity [J].J Exp Med, 2009, 206( 10): 2079-2089.
  • 5Beekum O V, Fleskens V, Kalkhoven E. Posttranslational modifications of PPAR~,: fine-tuning the metabolic master regulator [J]. Obesity (Silver Spring) , 2009, 17(2) : 213-219.
  • 6Hu E, Kim J B, Sarraf P, et ul. Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARγ [J].Science, 1996,274 (5295) :2100-2103.
  • 7Gelman L, Michalik L, Desvergne B, et al. Kinase signaling cascades that modulate peroxisome proliferator-activated receptors [J]. Curt Opin Cell Biol, 2005, 17(2) : 216-222.
  • 8lankova I, Petersen RK, Annicotte J, et al. Peroxisome proliferator-activated receptor γ recruits the positive transcription elongation factor b complex to activate transcription and promote adipogenesis [ J]. Mol Endoeriaol, 2006, 20(7) : 1494-1505.
  • 9Compe E, Drane P, Laurent C, et al. Dysregulation of the peroxisome proliferator-activated receptor target genes by XPD mutations [ J]. Mol Cell Biol, 2005, 25(14) : 6065-6076.
  • 10Helenius K, Yang Y, Alasaari J, et al. Mat1 inhibits peroxisome proliferator-aetivated receptor "y-mediated adipoeyte differentiation [J]. Mol Cell Biol, 2009, 29(2) : 315-323.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部